DIFFERENTIATED THYROID CANCER
Clinical trials for DIFFERENTIATED THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new DIFFERENTIATED THYROID CANCER trials appear
Sign up with your email to follow new studies for DIFFERENTIATED THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo tested for tough thyroid cancers
Disease control TerminatedThis phase II trial tested two immunotherapy drugs, durvalumab and tremelimumab, in 79 patients with advanced thyroid cancer that had progressed despite treatment. The goal was to see if the combination could slow or stop cancer growth. The study was terminated early, so the full…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Diabetes drug may ease thyroid treatment side effects
Symptom relief TerminatedThis small pilot study tested whether metformin, a common diabetes drug, could reduce side effects like dry mouth and taste changes from radioactive iodine treatment in people with thyroid cancer. Only 13 people took part, and the study was stopped early. The goal was to see if m…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Hunt for hidden thyroid cancer genes ends early
Knowledge-focused TerminatedThis study looked for new genes that might increase the risk of developing differentiated thyroid cancer. Researchers planned to analyze the complete DNA of people with thyroid cancer and their family members. The study was stopped early and involved 34 participants.
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: NA • Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC